比較分析卡托普利與美托洛爾治療慢型克山病臨床療效及對(duì)患者心臟功能的不同影響對(duì)比
本文選題:卡托普利 + 美托洛爾; 參考:《中國(guó)地方病防治雜志》2016年02期
【摘要】:目的比較卡托普利與美托洛爾治療慢型克山病的臨床療效及對(duì)患者心臟功能的影響。方法選擇2014年1月~2015年12月在本院治療的慢性克山病患者64例,根據(jù)隨機(jī)數(shù)字表分為卡托普利組(n=32)和美托洛爾組(n=32)。兩組患者均進(jìn)行常規(guī)基礎(chǔ)治療,卡托普利組在基礎(chǔ)治療的基礎(chǔ)上應(yīng)用卡托普利,美托洛爾組在基礎(chǔ)治療措施的基礎(chǔ)上使用美托洛爾。治療后分別對(duì)兩組患者死亡情況,臨床癥狀改善情況以及心功能改善情況進(jìn)行評(píng)估。結(jié)果卡托普利組病死率為3.13%,美托洛爾組無(wú)死亡。美托洛爾組治療后心悸發(fā)生率顯著高于卡托普利組(χ2=5.411,P0.05);卡托普利組治療后氣促和咳嗽發(fā)生率均顯著高于美托洛爾組(P0.05)。治療后兩組患者心動(dòng)過(guò)速、口唇發(fā)紺、以及浮腫等體征的發(fā)生率均較治療前顯著降低(P0.05)。治療后兩組患者LVESD和LVEDD均較治療前顯著降低(P0.05),LVEF均較治療前顯著升高(P0.05)。組間比較,治療前后兩組患者LVESD,LVEF和LVEDD比較差異均無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。組間比較,治療前后兩組患者心功能分級(jí)比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論卡托普利和美托洛爾均可顯著改善慢型克山病患者心功能,緩解臨床癥狀,但兩種藥物對(duì)部分臨床癥狀的緩解作用存在差異。
[Abstract]:Objective to compare the effect of captopril and metoprolol on chronic Keshan disease. Methods Sixty-four patients with chronic Keshan disease treated in our hospital from January 2014 to December 2015 were randomly divided into captopril group (n = 32) and metoprolol group (n = 32). The patients in the captopril group were treated with captopril and the metoprolol group were treated with metoprolol on the basis of the basic treatment. After treatment, the death, clinical symptoms and cardiac function of the two groups were evaluated. Results the mortality of captopril group was 3.13%, and that of metoprolol group was not. The incidence of palpitation in the metoprolol group was significantly higher than that in the captopril group (蠂 ~ 2 = 5.411), and the incidence of shortness of breath and cough in the captopril group was significantly higher than that in the metoprolol group (P 0.05). After treatment, the incidence of tachycardia, cyanosis of lips and swelling in both groups were significantly lower than those before treatment. After treatment, LVESD and LVEDD in both groups were significantly lower than those before treatment. There was no significant difference in LVEF and LVEDD between the two groups before and after treatment (P 0.05). There was no significant difference in cardiac function between the two groups before and after treatment (P 0.05). Conclusion Captopril and metoprolol can significantly improve cardiac function and relieve clinical symptoms in patients with chronic Keshan disease.
【作者單位】: 遼寧省鞍山市腫瘤醫(yī)院藥劑科;
【分類號(hào)】:R542.3
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 柳景華,丁燕生,任自文,韋星,陳健,吳林,羅維,周菁;快-慢型房室結(jié)折返性心動(dòng)過(guò)速的電生理特征和射頻消融治療[J];中國(guó)心臟起搏與心電生理雜志;1997年02期
2 錢志超;超聲心動(dòng)對(duì)潛在型與慢型克山病鑒別測(cè)試[J];中國(guó)地方病防治雜志;1997年03期
3 相有章,宋繼金,宋術(shù)亮,王林,屈福榮,管淑芬,張華芳;恢復(fù)期亞急型和慢型克山病患者動(dòng)態(tài)心電圖特點(diǎn)及預(yù)后意義[J];中國(guó)地方病學(xué)雜志;2004年01期
4 朱延河;魏瑾;;慢型克山病心衰發(fā)生發(fā)展機(jī)制的研究進(jìn)展[J];中國(guó)地方病防治雜志;2007年01期
5 朱延河,宋鴻彬,張永平,翟連榜,張春明,康軼君,劉作功,張曉峰;黃陵縣慢型克山病罹病現(xiàn)狀[J];中國(guó)地方病防治雜志;2000年05期
6 王成權(quán);劉秀武;馬學(xué)敏;王志國(guó);張宏斌;郭淑香;賈明山;;低分子右旋糖酐治慢型克山病20例效果觀察(摘要)[J];內(nèi)蒙古醫(yī)學(xué)雜志;1982年04期
7 胡駿,宋鴻彬,朱延河,翟連榜,張春明,張永平,康軼君,張曉峰;黃陵縣慢型克山病現(xiàn)狀調(diào)查——39例慢型克山病臨床分析[J];中國(guó)地方病學(xué)雜志;2002年01期
8 韓福生,周令望,劉立志,高彥輝,孫輝,劉藝,郭新利,汪中伯,于波,鐘學(xué)寬,于維漢;慢型克山病患者血清Ⅰ型前膠原羧基末端肽濃度的變化[J];中國(guó)地方病學(xué)雜志;2003年06期
9 王林,侍斌,鄒秋;604例慢型克山病心電圖分析[J];地方病通報(bào);2004年01期
10 何新科;楊杰;呂曉亞;陳平;李平安;張寶弟;燕曉峰;何玲霞;劉婷;羅鋒;;165例慢型克山病五年療效分析[J];陜西醫(yī)學(xué)雜志;2007年12期
相關(guān)會(huì)議論文 前2條
1 王林;侍斌;鄒秋;;604例慢型克山病心電圖分析[A];山東預(yù)防醫(yī)學(xué)會(huì)首屆學(xué)術(shù)年會(huì)資料匯編[C];2003年
2 相有章;管淑芬;王林;王秀紅;馬玉琴;劉俊清;劉源;;慢型克山病患者血栓素與前列腺環(huán)素含量變化觀察[A];山東預(yù)防醫(yī)學(xué)會(huì)第二屆學(xué)術(shù)年會(huì)論文匯編[C];2006年
,本文編號(hào):1978797
本文鏈接:http://www.sikaile.net/yixuelunwen/nfm/1978797.html